Tregalizumab

DB13073InvestigationalProtein Based Therapies

Tregalizumab has been used in trials studying the treatment of Rheumatoid Arthritis.

Mechanism: Pharmacologically active on T-cell surface glycoprotein CD4
Curator reviewed

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

382Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tregalizumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.